NIH Guide: Weekly Index for November 15, 2024

Funding Opportunities

• Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
  (PA-25-168)
  Office of the Director, NIH
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
• NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
  (PAR-25-054)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): February 10, 2025
• National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
  (PAR-25-081)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
  (PAR-25-133)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
  (PAR-25-165)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
  (PAR-25-167)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
  (PAR-25-170)
  National Institute of Neurological Disorders and Stroke
  National Cancer Institute
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
  (PAR-25-202)
  National Institute of General Medical Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
  (PAR-25-203)
  National Institute of General Medical Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
  (PAR-25-209)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
  (PAR-25-240)
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
  (PAR-25-241)
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
  (PAR-25-255)
  National Human Genome Research Institute
  National Cancer Institute
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
  (PAR-25-256)
  National Human Genome Research Institute
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
  (PAR-25-273)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
• Epitranscriptomics Crosstalks and Toxicants (EPCOT) (R01 Clinical Trials Not Allowed)
  (RFA-ES-25-001)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): February 06, 2025
• Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
  (RFA-ES-25-002)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37 Clinical Trial Not Allowed)
  (RFA-MD-25-001)
  National Institute on Minority Health and Health Disparities
  John E. Fogarty International Center
  Application Receipt Date(s): January 10, 2025
• BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
  (RFA-MH-26-170)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed)
  (RFA-NS-25-025)
  National Institute of Neurological Disorders and Stroke
  Office of the Director, NIH
  Application Receipt Date(s): Multiple dates, see announcement.